Fairvalue-Calculator Fairvalue-Calculator
EN DE

Benitec Biopharma Inc (BNTC) Fair Value & Analysis

Healthcare · US · Market cap $417M

Price$12.88
Fair Value$12.74
Upside-1.1%
Quality95/100
Evidence: Low Range $9.56 – $15.93

Fair value as of: Jun 24, 2026

✦ Find undervalued quality stocks — 34,000+ analysed Find stocks →

Analysis

Benitec Biopharma Inc (BNTC) currently trades at $12.88, while our model-based Fair Value estimate is $12.74 — implying the stock looks roughly 1.1% overvalued today. We read business quality at 95/100 (high quality), in the Healthcare sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: low).

About the company

Benitec Biopharma Inc., a clinical-stage biotechnology company, focuses on the development of novel genetic medicines. Its Silence and Replace, a DNA-directedRNA interference platform combines RNA interference with gene therapy to create medicines that simultaneously facilitate sustained silencing of disease-causing genes and concomitant delivery of wildtype replacement genes following a single administration of the therapeutic construct. The company is developing BB-301, an AAV-based gene therapy designed to silence the expression of the disease-causing gene for the treatment of oculopharyngeal muscular dystrophy related dysphagia. Benitec Biopharma Inc. is headquartered in Hayward, California.

Open the full interactive analysis →

Similar stocks

Vertex Pharmaceuticals Incorporated (VRTX34) -32% Regeneron Pharmaceuticals, Inc (REGN) -4% UCB SA (UCB) -23% argenx SE (ARGNF) -57% Samsung Biologics Co (207940) +1% Alnylam Pharmaceuticals, Inc (ALNY) -82%

Frequently asked questions

Is Benitec Biopharma Inc (BNTC) undervalued?
As of Jun 24, 2026, our model estimates a fair value of $12.74 versus a price of $12.88 — about −1% (overvalued). Model-based estimate, not financial advice.
What is the fair value of BNTC?
Our 21-model fair value for Benitec Biopharma Inc is $12.74 (as of Jun 24, 2026), built from audited fundamentals. The current price is $12.88.
What is the quality score of BNTC?
Benitec Biopharma Inc has a Quality Score of 95/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.